课题基金 / 基金详情

项目摘要

项目成果

HARALD VON BOEHMER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):胸腺移植物对T淋巴细胞生成最有效的贡献的性质尚不清楚,尽管已经描述了几个特征良好的祖细胞。其中一些细胞可以形成淋巴系和非淋巴系,另一些是淋巴系受限的,还有一些是T淋巴系受限的。具有T细胞系限制潜力的细胞,循环T细胞祖细胞(CTP),最近在血液中被描述,借助于TCR1前控制的报告基因。在这里,我们建议进一步研究CTP及其后代的表型特征,并更详细地分析它们在T细胞生成和对T细胞谱系的承诺方面的有效性。此外,通过分析Notch依赖转录缺陷的前体细胞产生具有CTP表面表型的细胞,将在可逆抑制Notch依赖转录的小鼠中解决T谱系承诺的Notch依赖。随后,在分离CTP并解除转录阻断后,将确定其功能潜力。最后,CTP的基因表达将与多能(LSK)和胸腺(ETP)前体细胞的基因表达进行比较,试图将这些细胞置于分化途径中。将特别强调LRF基因对淋巴细胞早期前体细胞中对抗Notch的基因调控。在第二个目标中,将通过在将骨髓或血细胞注入Il-7ra缺陷受体之前消耗这些前体来比较几种特征良好的胸腺外前体生成T细胞的效果。在其他研究中,IL-7R1-cre的血统命运追踪将被用来确定表达IL-7R1的前体对胸腺内前体(如ETP)的贡献。此外,通过将胸腺供体来源的细胞移植到含有OP9-DL1饲养层细胞的培养物中,在限制稀释的条件下,在注射细胞24小时后,将比较细胞到胸腺的短期潜力。一旦建立了具有多潜能(原型LSK)、淋巴限制潜力(原型CLP)或T系限制潜力(原型CTP)的不同前体的信息,这些子集将被已建立的标记进一步细分,以便尽可能精确地定位最相关的前体。总体而言,该项目旨在建立胸腺外T细胞谱系承诺的机制,以及确定胸腺外T淋巴细胞生成最有效的前体。公共卫生相关性:该项目旨在识别和表征骨髓和血液中最有效的细胞,这些细胞在不同条件下允许重建T细胞免疫系统,以保护其免受感染和恶性肿瘤。胸腺外T细胞前体的鉴定将有助于通过X-射线和/或导致T细胞耗尽的细胞毒性药物治疗恶性肿瘤后更快地再生免疫系统。
英文摘要
DESCRIPTION (provided by applicant): The nature of thymus immigrants that contribute most effectively to T lymphopoiesis is unknown even though several well-characterized progenitors have been described. Some of these cells can give rise to lymphoid and non-lymphoid lineages, others are lymphoid-restricted and yet others are T lymphoid lineage-restricted. Cells with T lineage-restricted potential, circulating T cell progenitors (CTP), have recently been described in the blood with the aid of a pre-TCR1- controlled reporter gene. Here it is proposed to further phenotypically characterize CTP and their progeny and to analyze their efficacy in T cell generation and commitment to the T cell lineage in further detail. Furthermore, the Notch dependence of T lineage commitment will be addressed in mice with reversible inhibition of Notch-dependent transcription by analyzing the generation of cells with a CTP surface phenotype from precursors that are deficient in Notch- dependent transcription. Subsequently, after isolation of CTP and relieving the transcriptional block, the functional potential will be determined. Finally, gene expression of CTP will be compared with that of multipotent (LSK) and intrathymic (ETP) precursors in an attempt to place these cells in a differentiation pathway. Special emphasis will be given to gene regulation by the LRF gene that antagonizes Notch in early precursors of lymphoid cells. In a second aim, the efficacy of several well-characterized extrathymic precursors to generate T cells will be compared by depleting such precursors prior to injecting bone marrow or blood cells into Il-7ra- deficient recipients. In additional studies lineage fate tracing by IL-7R1-cre will be used to determine the contribution of IL-7R1-expressing precursors to intrathymic precursors such as ETP. Furthermore, the short-term potential of cells to home to the thymus will be compared 24 hours after injection of cells by explanting intrathymic donor-derived cells under conditions of limiting dilution into cultures containing OP9-DL1 feeder cells. Once information on different precursors with either multipotential (prototype LSK), lymphoid-restricted potential (prototype CLP) or T lineage-restricted potential (prototype CTP) has been established these subsets will be further subdivided by already established markers in order to pinpoint the most relevant precursors as precisely as possible. Overall this project aims at establishing mechanisms of extrathymic T lineage commitment as well as identifying the most potent extrathymic precursors for T lymphopoiesis. PUBLIC HEALTH RELEVANCE: This project aims at the identification and characterization of the most effective cells in bone marrow and blood that under different conditions permit the reconstitution of the T cell immune system that protects from infection and malignancy. Identification of the extrathymic T cell precursors will help in the faster regeneration of the immune system after treatment of malignancy by x- irradiation and/or cytotoxic drugs that result in T cell depletion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Pathways in T Cell Development and T-ALL
  • 批准号:
    7780947
  • 项目类别:
  • 资助金额:
    $21.23万
  • 财政年份:
    2010
  • 负责人:
    HARALD VON BOEHMER
  • 依托单位:
Molecular Pathways in T Cell Development and Thymic Lymphoma
  • 批准号:
    6989689
  • 项目类别:
  • 资助金额:
    $21.01万
  • 财政年份:
    2004
  • 负责人:
    HARALD VON BOEHMER
  • 依托单位:
pTa-controlled reporter to identify lymphoid precursor
  • 批准号:
    7003715
  • 项目类别:
  • 资助金额:
    $41.75万
  • 财政年份:
    2003
  • 负责人:
    HARALD VON BOEHMER
  • 依托单位:
Extrathymic T cell precursors: commitment and efficacy
  • 批准号:
    7529944
  • 项目类别:
  • 资助金额:
    $39.41万
  • 财政年份:
    2003
  • 负责人:
    HARALD VON BOEHMER
  • 依托单位:
海外基金